C

Cuorips Inc
TSE:4894

Watchlist Manager
Cuorips Inc
TSE:4894
Watchlist
Price: 4 715 JPY -0.53% Market Closed
Market Cap: 37.9B JPY
Have any thoughts about
Cuorips Inc?
Write Note

Cuorips Inc
Investor Relations

Cuorips Inc is a Japan-based company mainly engaged in the development and commercialization of regenerative medical products and contract development and manufacturing organization (CDMO) business. The company is headquartered in Chuo-Ku, Tokyo-To and currently employs 46 full-time employees. The company went IPO on 2023-06-27. The main product of the Company is human iPS cell-derived cardiomyocyte sheets. The firm provides regenerative medical products for the heart and other areas through in-house research, joint research with universities and other research institutions and major pharmaceutical companies. The firm operates CDMO business using CLiC-1, a commercial cell culture and processing facility with an integrated laboratory based on the Company's original design concept.

Show more

Earnings Calls

No Earnings Calls Available

Management

Takayuki Kusanagi
President, CEO & Director
No Bio Available
Taichi Kobayashi
Chief Financial Officer
No Bio Available
Yoshiki Sawa
CTO & Director
No Bio Available
Tadayuki Tanimura
Executive Vice President
No Bio Available

Contacts

Address
TOKYO-TO
Chuo-Ku
507, Nihonbashi Life Science Bldg. 2, 3-11-5, Nihonbashi Hon-cho
Contacts
+81362310043
cuorips.co.jp